Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of bempedoic acid in patients with hyper-LDL cholesterolemia in Japan
jRCT2031220563Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bempedoic acid in hypercholesterolemia and hyperlipidemia, sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Safety and tolerability of bempedoic acid over 52 weeks. Started Feb 2023; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemiahyperlipidemia
Beyond the preview
Go deeper on jRCT2031220563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220563.